BrainFectIN™ enables nucleic acids delivery into central nervous system of small animals.

• Targeted process (stereotaxic injection)
• Good transfection efficiency
• Reduction of the injection volume
• Reduction of the DNA doses
• Minimized toxicity
• Low immunogenicity
• Rapid and long-term transgene expression

Major difficulties with gene delivery in the central nervous system is the weakness of standard non-viral gene carriers and the limitations associated to the use of viral particles (time-consuming and requires additional saftey precautions). Unlike these methods, BrainFectIN™ is an original non-viral formulation that allows safe, easy and efficient nucleic acids delivery into central nervous system of small animals. This transfection reagent allows transfection of neural cells in specific brain following stereotaxic injection, with low immunogenicity and rapid and long-term transgene expression. BrainFectIN™ has been designed by R and D team to meet in vivo grade quality (reagents performed under high manufacturing and quality standards and tested by strict quality controls).